Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation

Journal of General Virology

Volumn 78, Issue 8, 1997, Pages 2041-2048

  Vanderplasschen, Alain ^a   Hollinshead, Michael ^a   Smith, Geoffrey L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; VIRUS ANTIBODY;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ELECTRON MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRION; VIRUS INFECTION; VIRUS PLAQUE;

ANIMALIA; VACCINIA; VACCINIA VIRUS;

EID: 0030849402     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-8-2041     Document Type: Article

References (39)

1. Alcamí, A. & Smith, G. L. (1996). A mechanism for the inhibition of fever by a virus. Proceedings of the National Academy of Sciences, USA 93, 11029-11034.
2. Appleyard, G. & Andrews, C. (1974). Neutralizing activities of antisera to poxvirus soluble antigens. Journal of General Virology 23, 197-200.
3. Appleyard, G., Hapel, A. J. & Boulter, E. A. (1971). An antigenic difference between intracellular and extracellular rabbitpox virus. Journal of General Virology 13, 9-17.
4. Blasco, R. & Moss, B. (1992). Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. Journal of Virology 66, 4170-4179.
5. Boulter, E. A. (1969). Protection against poxviruses. Proceedings of the Royal Society of Medicine 62, 295-297.
6. Boulter, E. A. & Appleyard, G. (1973). Differences between extracellular and intracellular forms of poxviruses and their implications. Progress in Medical Virology 16, 86-108.
7. Cudmore, S., Cossart, P., Griffiths, G. & Way, M. (1995). Actin-based motility of vaccinia virus. Nature 378, 636-638.
8. Czerny, C. P. & Mahnel, H. (1990). Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies. Journal of General Virology 71, 2341-2352.
9. Doms, R. W., Blumenthal, R. & Moss, B. (1990). Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. Journal of Virology 64, 4884-4892.
10. Duncan, S. A. & Smith, G. L. (1992). Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. Journal of Virology 66, 1610-1621.
11. Engelstad, M. & Smith, G. L. (1993). The vaccinia virus 42 kDa envelope protein is required for envelopment and egress of extracellular virus and for virulence. Virology 194, 627-637.
12. Engelstad, M., Howard, S. T. & Smith, G. L. (1992). A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188, 801-810.
13. Essani, K. & Dales, S. (1979). Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion. Virology 95, 385-394.
14. Hanson, C. V., Riggs, J. L. & Lennette, E. H. (1978). Photochemical inactivation of DNA and RNA viruses by psoralen derivatives. Journal of General Virology 40, 345-358.
15. Hirt, P., Hiller, G. & Wittek, R. (1986). Localization and fine structure of a vaccinia virus gene encoding an envelope antigen. Journal of Virology 58, 757-764.
16. Ichihashi, Y. (1996). Extracellular enveloped vaccinia virus escapes neutralization. Virology 217, 478-485.
17. Ichihashi, Y., Matsumoto, S. & Dales, S. (1971). Biogenesis of pox viruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology 46, 507-532.
18. Isaacs, S. N. & Moss, B. (1994). Inhibition of complement activation by vaccinia virus. In Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses, pp. 55-66. Edited by G. McFadden. Austin: R. G. Landes.
19. Isaacs, S. N., Wolffe, E. J., Payne, L. G. & Moss, B. (1992). Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. Journal of Virology 66, 7217-7224.
20. McIntosh, A. A. G. & Smith, G. L. (1996). Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. Journal of Virology 70, 272-281.
21. Mackett, M., Smith, G. L. & Moss, B. (1985). The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning: A Practical Approach, pp. 191-211. Edited by D. M. Glover. Oxford: IRL Press.
22. Mason, P. W., Rieder, E. & Baxt, B. (1994). RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proceedings of the National Academy of Sciences, USA 91, 1932-1936.
23. Parkinson, J. E. & Smith, G. L. (1994). Vaccinia virus gene A36R encodes a Mr 43-50K protein on the surface of extracellular enveloped virus. Virology 204, 376-390.
24. Payne, L. G. (1978). Polypeptide composition of extracellular enveloped vaccinia virus. Journal of Virology 27, 28-37.
25. Payne, L. G. (1979). Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. Journal of Virology 31, 147-155.
26. Payne, L. G. (1980). Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia virus. Journal of General Virology 50, 89-100.
27. Payne, L. G. (1992). Characterization of vaccinia virus glycoproteins by monoclonal antibody preparations. Virology 187, 251-260.
28. Payne, L. G. & Kristensson, K. (1985). Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo. Journal of General Virology 66, 643-646.
29. Payne, L. G. & Norrby, E. (1976). Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. Journal of General Virology 32, 63-72.
30. Roos, N., Cyrklaff, M., Cudmore, S., Blasco, R., Krijnse-Locker, J. & Griffiths, G. (1996). A novel immunogold cryoelectron microscopic approach to investigate the structure of the intracellular and extracellular forms of vaccinia virus. EMBO Journal 15, 2343-2355.
31. Roper, R. L., Payne, L. G. & Moss, B. (1996). Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. Journal of Virology 70, 3753-3762.
32. 2+ influx into infected cells. Journal of Virology 70, 905-914.
33. Schmelz, M., Sodeik, B., Ericsson, M., Wolffe, E. J., Shida, H. G. H. & Griffiths, G. (1994). Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. Journal of Virology 68, 130-147.
34. Shida, H. (1986). Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology 150, 451-462.
35. Tooze, J., Hollinshead, M., Reis, B., Radsak, K. & Kern, H. (1993). Progeny vaccinia viruses and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. European Journal of Cell Biology 60, 163-178.
36. Turner, G. S. & Squires, E. J. (1971). Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus. Journal of General Virology 13, 19-25.
37. Vanderplasschen, A. & Smith, G. L. (1997). An novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. Journal of Virology 71, 4032-4041.
38. Wand, S., He, R., Patarapotikul, J., Innis, B. L. & Anderson, R. (1995). Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 213, 254-257.
39. Wolffe, E. J., Isaacs, S. N. & Moss, B. (1993). Deletion of the vaccinia virus B5R gene encoding a 42-kiloDalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. Journal of Virology 67, 4732-4741.